Simplex Trading’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Sell
429,600
-385,300
-47% -$29.7M 0.02% 322
2025
Q4
$64.7M Buy
814,900
+187,900
+30% +$14.8M 0.04% 227
2025
Q3
$47.3M Sell
627,000
-420,900
-40% -$28.8M 0.02% 366
2025
Q2
$72.3M Sell
1,047,900
-440,600
-30% -$28.9M 0.04% 216
2025
Q1
$101M Sell
1,488,500
-7,600
-0.5% -$455K 0.06% 138
2024
Q4
$67.2M Buy
1,496,100
+12,200
+0.8% +$684K 0.04% 241
2024
Q3
$93.3M Buy
1,483,900
+267,600
+22% +$15.6M 0.05% 177
2024
Q2
$71.8M Buy
1,216,300
+29,300
+2% +$1.83M 0.04% 223
2024
Q1
$94.7M Buy
1,187,000
+629,400
+113% +$48.1M 0.05% 190
2023
Q4
$44M Sell
557,600
-603,900
-52% -$43M 0.03% 388
2023
Q3
$81.1M Buy
1,161,500
+177,500
+18% +$12.6M 0.06% 174
2023
Q2
$68M Buy
984,000
+302,000
+44% +$21.5M 0.06% 215
2023
Q1
$50.7M Buy
682,000
+116,800
+21% +$9.79M 0.04% 276
2022
Q4
$52.7M Buy
565,200
+118,800
+27% +$11.5M 0.06% 260
2022
Q3
$42.6M Buy
446,400
+28,400
+7% +$2.81M 0.05% 288
2022
Q2
$38.7M Sell
418,000
-276,700
-40% -$27M 0.04% 305
2022
Q1
$70.3M Sell
694,700
-197,500
-22% -$20.7M 0.06% 212
2021
Q4
$92M Buy
892,200
+221,000
+33% +$20.4M 0.09% 166
2021
Q3
$55.2M Buy
671,200
+32,600
+5% +$2.73M 0.05% 230
2021
Q2
$53.3M Buy
638,600
+633,598
+12,667% +$51.9M 0.05% 232
2021
Q1
$37.6M Buy
+5,002
New +$364K 0.07% 167
2020
Q4
Sell
-4,577
Closed -$26.7M 8450
2020
Q3
$26.7M Sell
4,577
-510
-10% -$31.7K 0.04% 273
2020
Q2
$33M Sell
5,087
-1,385
-21% -$87.2K 0.05% 202
2020
Q1
$38.4M Buy
6,472
+1,966
+44% +$131K 0.07% 149
2019
Q4
$33.5M Sell
4,506
-1,553
-26% -$109K 0.07% 172
2019
Q3
$38.2M Sell
6,059
-131
-2% -$7.76K 0.11% 121
2019
Q2
$33.7M Sell
6,190
-2,418
-28% -$130K 0.09% 137
2019
Q1
$46.4M Buy
8,608
+6,507
+310% +$402K 0.13% 100
2018
Q4
$13.8M Buy
2,101
+714
+51% +$53.3K 0.04% 274
2018
Q3
$10.9M Sell
1,387
-1,230
-47% -$87.9K 0.04% 339
2018
Q2
$16.8M Buy
2,617
+724
+38% +$47.7K 0.07% 211
2018
Q1
$1.22M Sell
1,893
-1,086
-36% -$77.9K 0.05% 320
2017
Q4
$1.96M Buy
2,979
+753
+34% +$54.7K 0.08% 192
2017
Q3
$957K Sell
2,226
-466
-17% -$36.9K 0.04% 399
2017
Q2
$1.25M Sell
2,692
-3,847
-59% -$304K 0.05% 294
2017
Q1
$2.69M Buy
6,539
+2,792
+75% +$223K 0.12% 154
2016
Q4
$1.45M Buy
3,747
+2,230
+147% +$180K 0.09% 190
2016
Q3
$482K Sell
1,517
-596
-28% -$56.3K 0.03% 524
2016
Q2
$242K Buy
2,113
+1,180
+126% +$118K 0.02% 891
2016
Q1
$142K Buy
933
+39
+4% +$3.79K 0.01% 1084
2015
Q4
$157K Buy
894
+29
+3% +$2.84K 0.01% 1041
2015
Q3
$495K Buy
865
+399
+86% +$41.9K 0.04% 450
2015
Q2
$23K Buy
466
+267
+134% +$27.3K ﹤0.01% 2333
2015
Q1
$32K Sell
199
-132
-40% -$13.4K ﹤0.01% 1899
2014
Q4
$67K Buy
+331
New +$29.2K 0.01% 1168

Other funds holding CVS

Simplex Trading's CVS Position: Q1 2026 in Review

Simplex Trading increased its CVS Health (CVS) stake by 61% in Q1 2026, buying an estimated $2.16M and bringing the position to 74,158 shares worth $5.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Simplex Trading first reported a position in CVS in Q1 2016 and has held it in 30 quarters since. The position peaked at $33.8M in Q3 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Simplex Trading held 74,158 shares of CVS Health worth $5.33M as of Q1 2026.
  • Simplex Trading bought 27,987 CVS Health shares in Q1 2026, an estimated $2.16M.
  • CVS Health made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #1073 holding.
  • Simplex Trading first reported a position in CVS Health in Q1 2016 and has held it in 30 quarters since.
  • Simplex Trading's CVS Health position peaked at $33.8M in Q3 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.